Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drug Compounding Can't Be Justified By Price, FDA Says

Executive Summary

Guidance on compounding commercially available drugs states that prescribers can order them as long as there's a clinical difference for the patient – a standard that likely helps Daraprim but not Lucentis.

You may also be interested in...



FDA Highlights Advanced Drug Manufacturing Approaches In Budget Plan

FDA wants more companies to adopt continuous manufacturing, which could expand the US manufacturing base.

FDA Backs Off From Early Citations Of Compounder Sterility Issues

A month after compounding pharmacists' latest annual visit to Congress, FDA has acted on one of their chief complaints – investigators citing them for GMP violations even in cases where the agency later acknowledged they were exempt.

Drug Pricing Panacea Or Just PR Victory? Expedited ANDAs May Have Limited Impact

In theory, reviewing generic applications faster should speed competition; in practice, FDA's new policy likely won't make too much difference.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS118727

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel